# Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2

> **NCT05745467** · PHASE4 · WITHDRAWN · sponsor: **University of Iowa**

## Conditions studied

- SARS-CoV-2 Acute Respiratory Disease

## Interventions

- **DRUG:** Povidone Iodine 5% Soln,Top,Kit

## Key facts

- **NCT ID:** NCT05745467
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-07-03
- **Primary completion:** 2025-07-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Wouldn't be able to get enough patients. Never started the study. Suspended the IRB form.
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05745467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05745467, "Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05745467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*